معرفی
Jonas Bergh is a Professor and Senior Professor in the Department of Oncology-Pathology at Karolinska Institutet. His research focuses on optimizing breast cancer treatment through risk profiling and predictive markers, emphasizing personalized approaches. He leads a group investigating combinations of conventional drugs, targeted therapies, and immunotherapies using multiomics tools.
**Educations**: Doctoral education details not explicitly listed, but his roles suggest advanced training in oncology and molecular biology. **Current Projects**: Includes analyses from the PANTHER study, EORTC10994/BIG1-00 trials, and registry-based studies to refine treatment strategies and improve patient outcomes. **Grants**: Received SEK 75M (Swedish Cancer Society) and SEK 33M (Radiumhemmets Forskningsfonder) in recent years.
**Research Interests**: Breast cancer biology, precision medicine, tumor resistance mechanisms, and translational oncology. He explores biomarkers and genomic changes influencing treatment response in metastatic vs. early-stage cancers. **Labs/Teams**: Leads the 'Strategies for optimal treatment selection' group with a team including PhD students and bioinformaticians.
**Awards**: 2024 Grand Silver Medal for contributions to oncology. His work bridges clinical and experimental research to advance individualized cancer care.
